MedPath

Study to Evaluate Safety & Effectiveness of Spinal Sealant

Not Applicable
Completed
Conditions
Cerebrospinal Fluid Leakage, Subdural
Interventions
Device: Spinal Sealant
Other: Standard of Care
Registration Number
NCT00444067
Lead Sponsor
Integra LifeSciences Corporation
Brief Summary

To evaluate a spinal sealant as an adjunct to sutured dural repair compared to standard of care techniques.

Detailed Description

Neurosurgical procedures in the spine often involve incision of the dura mater to access the spinal cord. If the dural incision is not properly repaired and watertight closure is not achieved cerebrospinal fluid (CSF) can escape presenting a risk for significant morbidity. The most frequent complication of CSF leak is recurring headache complicated with symptoms of nausea and vomiting. Furthermore fluid collection under skin prevents proper wound healing and may lead to wound breakdown and infection of the incision or both. Persistent CSF leak has also been associated with the development of cerebellar hemorrhage and subdural hematoma. Primary repair and watertight closure are paramount to minimizing risk and sequelae associated with CSF leak.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
98
Inclusion Criteria
  • Subjects scheduled for a spinal procedure that requires a dural incision
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Spinal Sealant SystemSpinal SealantSpinal Sealant System
Standard of CareStandard of CareStandard of care methods as an adjunct to sutured dural repair
Primary Outcome Measures
NameTimeMethod
Percent(%) Success in Obtaining a Watertight Closure Following Assigned Treatment (Spinal Sealant or Control)Intra-operative

Percent(%) success in obtaining a watertight closure following assigned treatment (Spinal Sealant or Control) where success is defined as:

A watertight closure of the dural repair intraoperatively after study treatment, confirmed by Valsalva maneuver at 20-25 cm H2O for 5-10 seconds.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Confluent Surgical, Inc.

🇺🇸

Bedford, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath